Curcuma longa L. = Curcuma domestica Val. — A comprehensive evidence-based clinical monograph covering anti-inflammatory, hepatoprotective, neuroprotective, antioxidant and anticancer pharmacology of curcumin across whole-plant rhizome, essential oil, and standardised extract preparations.
Curcuma longa L. is a rhizomatous herbaceous perennial of the Zingiberaceae family, one of the most extensively researched medicinal plants in the world. Its therapeutic spectrum spans anti-inflammation, hepatoprotection, neuroprotection, antioxidation, anticancer activity, immunomodulation and metabolic regulation — largely attributed to curcuminoids, primarily curcumin, which inhibit NF-κB and multiple inflammatory cascades. The Indian prevalence of Alzheimer's disease is 4.4 times lower than in the United States in the 70–79 age group, a finding partly attributed to habitual turmeric consumption.
Curcuma longa is an erect herbaceous species, 60 to 100 cm tall, with a creeping rhizome system. The rhizomes are the principal part used medicinally — they form the characteristic "fingers of curcuma," with an intensely golden-yellow to orange section displaying a beautiful aromatic colour. The plant was introduced to the Antilles and Réunion island from its native Far East origins.
The aromatic rhizomatous stock with its vivid golden-yellow cross-section is the botanically and pharmacologically defining feature of this species — the source of curcuminoids and essential oil. India is the world's largest producer, providing approximately 80% of the global turmeric supply. It is a principal component of curry, alongside pepper, nutmeg, ginger and fenugreek.
Pharmacopoeial Note
The French Pharmacopoeia includes a monograph for Curcuma longa derived from the Chinese Pharmacopoeia, developed within a cooperation agreement between AFSSAPS and the State Food and Drug Administration of China. The monograph describes a thin-layer chromatography assay to differentiate Curcuma longa from Curcuma xanthorrhiza. [2]
Turmeric holds a central position in South Asian cuisine, medicine and ritual. As a core constituent of curry, it has been in daily use across India for millennia. Modern pharmacological research now substantiates what traditional medicine long practised — that the rhizome carries a remarkable spectrum of biological activities, primarily through its curcuminoid fraction.
Turmeric is one of the defining ingredients of curry, alongside chilli, nutmeg, ginger and fenugreek. Daily dietary consumption at culinary doses across South Asian populations represents one of the largest natural phytotherapy experiments in human history.
Turmeric rhizome is officially listed in the French Pharmacopoeia, List A — reflecting its established quality and safety profile. The monograph was developed in collaboration with the Chinese Pharmacopoeia. [1],[2]
The striking 4.4-fold lower prevalence of Alzheimer's disease in rural India compared to the United States, documented in the Indo-US study, has prompted extensive research into curcumin as a beta-amyloid inhibitor and neuroprotector.
In China, turmeric is administered preventively to patients with abnormal cells and a predisposition to oesophageal cancer — reflecting its recognised anti-carcinogenic potential at the clinical level.
Bioavailability Note
"The poor bioavailability of curcumin is significantly compensated by use of the total extract — notably through the presence of aromatic turmerones."
Wikiphyto Curcuma — Ref [50]
Piperine from black pepper increases curcumin absorption and bioavailability by up to 2000%. Strongly recommended to include piperine in all curcumin formulations to inhibit glucuroconjugation. [88]
Two principal parts used, available in multiple pharmaceutical forms each with distinct biochemical profiles.
The "fingers of curcuma" — dried, powdered rhizome or fresh juice. Available as mother tincture, dry extract, EPS (fresh plant extract), rhizome powder, and fresh turmeric juice. Source of curcuminoids (coloured fraction) and essential oil.
Steam-distilled essential oil from the rhizome. Distinct pharmacological profile rich in ar-turmerone, alpha- and beta-turmerone, and zingiberene. Fresh-plant EO has superior antioxidant potential versus dried rhizome EO — due to alpha-turmerone content (~20% in fresh vs. trace in dried).
Curcuminoid-rich extracts (typically 95% curcuminoids), often combined with piperine for enhanced bioavailability. Available as capsules, liposomes, phytosomes (lecithin complex), gamma-cyclodextrin encapsulates, and micronised powder formulations.
Three biochemical fractions — whole rhizome, bud compounds, and essential oil — each with a distinct compound profile driving specific therapeutic effects.
Anti-inflammatory
Inhibits NF-κB, COX-2, phospholipase, lipoxygenase, TNF, IL-12, MCP-1
Hepatoprotective
Prevents CCl4, paracetamol, alcohol-induced liver damage; anti-fibrotic
Neuroprotective
Blocks beta-amyloid accumulation; destroys existing plaques; protects dopaminergic neurons
Anticancer
Inhibits angiogenesis, tumour promotion and growth; pro-apoptotic
Curcumin vs. Whole Turmeric: Even when deprived of curcumin, turmeric retains anti-inflammatory, anticancer and antidiabetic activities — via turmerine, turmerone, elemene, furanodiene, curdione, bisacurone, cyclocurcumin, calebine A and germacrone. Complex synergies are at work within the totum. [49]
PPAR-γ activator. [6],[7] Inhibits phospholipase, lipoxygenase, COX-2, leukotrienes, thromboxane, prostaglandins, NO, collagenase, elastase, hyaluronidase, MCP-1, TNF, IL-12. [8],[9],[10],[11] Demonstrated on acute and chronic inflammation, arthritis, and granuloma models. Curcumin inhibits IL-1β-induced collagen type-II reduction — key in osteoarthritis pathogenesis. [12]
Demethoxycurcumin may have more potent anti-inflammatory action than curcumin itself. [13],[14] All curcuminoids — curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones — differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism.
Prevents hepatocyte cytotoxicity induced by carbon tetrachloride [16] and paracetamol. [17] Prevents methotrexate-induced liver damage [18] and dimethylbenzanthracene. [19] Preventive against cirrhosis and hepatic fibrosis. [20],[21] Also protects against alcohol-induced experimental liver disease by suppressing NF-κB-dependent gene induction and restoring antioxidant enzymes. [22],[23] [15]
Stimulates bile flow and contraction of the gallbladder — classic cholagogue action substantiated in pharmacological studies. [24] This property underlies the contraindication in large biliary calculi.
Curcumin protects the kidney against oxidative stress. [25] Curcumin and its derivatives act as antioxidants, free radical scavengers and hepatoprotectors. [26]
Cytoprotective; anti-Helicobacter pylori; cholagogue. [27] Note: ulcerogenic at high doses. Curcumin may reduce ulcerative colitis relapse. [28]
Indirect action on adrenal cortex. Inhibits IL and TNF production. Curcumin and derivatives inhibit glucocorticoid production via selective 11β-HSD1 inhibition in liver and adipose tissue — reducing blood glucose, cholesterol, triglycerides and LDL in high-fat diet rats, with potential for metabolic syndrome prevention. [29]
Immunomodulant and immunostimulant. [30] Inhibits HIV-1 integrase, which catalyses the interaction of the viral genome with the infected cell's DNA. [31]
Reduces intestinal cholesterol absorption. [32] Clinically studied for lipid-lowering in acute coronary syndrome patients with significant reductions in LDL and total cholesterol.
Improves diabetes-induced endothelial dysfunction. [34] Improves lipid peroxidation especially with photo-irradiated curcumin. [35] [33]
Curcumin inhibits platelet aggregation mediated by PAF (platelet-activating factor) and arachidonic acid, inhibits thromboxane A2 synthesis without PKC involvement. [36]
Classical emmenagogue (stimulates menstrual flow) and anthelmintic (anti-parasitic) properties well established in traditional use and supported by ethnopharmacological data.
Protects against chronic anterior uveitis; clinical evidence supports protective effects in this often refractory inflammatory eye condition.
Blocks beta-amyloid protein accumulation and destroys existing plaques. [37] Improves behaviour, quality of life and longevity in animal models. [38]
Curcumin potentiated by piperine protects against 6-OHDA-induced neurotoxicity [40] and quinolinic acid-induced neurodegeneration (Huntington's disease model). [41] [39]
Reduces oxidative stress; blocks depletion of antioxidant molecules and enzymes in erythrocytes and liver; reduces lipid peroxidation. Curcumin and derivatives are potent free radical scavengers and hepatoprotectors.
Role of curcumin in cancer prevention established. [42] Anticancer potentials in ovarian cancer, lymphoma cells [43], hepatocarcinoma [44], and colorectal cancer [45] — increases body weight, reduces serum TNF-alpha, increases apoptosis and p53 expression in tumour tissue. Curcumin inhibits carcinogenesis at three stages: angiogenesis, tumour promotion and tumour growth. [46]
Chemoprotective versus anticancer chemotherapies — protective against cardiac, hepatic and renal toxicity of doxorubicin. [47] Antioxidant; promotes apoptosis of cancer cells; modulates proto-oncogene expression; anti-neoangiogenic.
Inhibits skin cancer development in experimental models. [48] Used prophylactically in China for patients with oesophageal abnormal cells.
Even curcumin-free turmeric retains anti-inflammatory, anticancer and antidiabetic activities through turmerine, turmerone, elemene, furanodiene, curdione, bisacurone, cyclocurcumin, calebine A and germacrone — complex synergies are operative. Aromatic turmerones compensate for curcumin's poor bioavailability in the totum. [49],[50]
The ethanolic extract of Curcuma aromatica exerts repellent activity against various biting insects, including Aedes aegypti, the dengue mosquito vector. [51],[52]
Pharmacological activities specific to the steam-distilled essential oil fraction of Curcuma longa rhizome.
EO from fresh plant has superior antioxidant potential compared to EO from dried rhizomes. [53] Alpha-turmerone (~20% in fresh EO) is present only in trace amounts in dried-rhizome EO. [54]
Antioxidant, anti-inflammatory and antinociceptive activities established. [55],[56] Antidiabetic, anticancer, platelet aggregation inhibitor, neuroprotective and nephroprotective. [57]
Inhibits Streptococcus mutans biofilm formation — relevant to dental caries prevention. [58] Also antifungal, antiparasitic and active against Leishmania amazonensis. [59]
Reduces hepatic steatosis (fatty liver). [60] Complementary to the whole-plant hepatoprotective activity.
Sesquiterpene fraction of the EO provides hepatoprotection against galactosamine-induced liver damage — distinct mechanism from curcumin-mediated hepatoprotection. [61]
Ar-turmerone (aromatic turmerone) is neuroprotective — inhibits NF-κB, JNK, and p38 MAPK signalling in amyloid beta-stimulated microglia, with significant anti-neuroinflammatory activity. [62]
Anticancer activity demonstrated specifically against liver cancer cells. Active constituents include turmerones, elemene and related sesquiterpene ketones.
Evidence-based indications for whole-plant preparations, supported by clinical trials, systematic reviews and pharmacological data.
Compound-level mechanisms through which Curcuma longa's principal actives exert their pharmacological effects, with key clinical remarks on bioavailability.
Inhibition of lysosomal enzyme activity. Action on prostaglandin synthesis. Modulation of granulocyte response to inflammatory stimuli. Inhibits NF-κB (master switch of inflammation), COX-2, lipoxygenase, phospholipase A2, and multiple downstream cytokines including TNF-α, IL-1β, IL-6, IL-12. Activates PPAR-γ. [6],[8],[9]
Direct free radical scavenging. Restores antioxidant enzymes (glutathione peroxidase, SOD, catalase) in erythrocytes and liver. Inhibits lipid peroxidation. Chelates transition metal ions that catalyse radical generation. Curcumin and derivatives (diarylheptanoids) are potent hepatoprotectors via antioxidant mechanisms. [26]
Inhibits all three stages of carcinogenesis: angiogenesis, tumour promotion and tumour growth. Pro-apoptotic via p53 upregulation and bcl-2 modulation. Inhibits proto-oncogene expression. Anti-neoangiogenic. Inhibits HIV-1 integrase — potential antiviral mechanism relevant to AIDS-related cancers. [43],[45]
Limited bioavailability due to reduced intestinal absorption and rapid elimination kinetics — galenic formulation is critically important. [87] Piperine increases bioavailability of curcumin significantly. [88] Note: a large body of studies used pure curcumin — not all properties are directly transposable to the spice itself.
Curcumin and derivatives selectively inhibit 11β-hydroxysteroid dehydrogenase 1 in liver and adipose tissue — reducing glucocorticoid production locally, thereby decreasing blood glucose, cholesterol, triglycerides and LDL. Improves insulin receptor sensitivity and beta-cell function. [29]
Traditional culinary use: 1 teaspoon of turmeric powder per day is a common dietary intake level. The Wikiphyto source notes a range up to 3 tablespoons cited from a practitioner resource — this reflects culinary tradition, not a clinical dosage recommendation. For therapeutic use, standardised extracts at validated doses should be used under medical supervision. To improve bioavailability, mix with a fat (e.g. olive oil) and freshly ground black pepper (piperine). The ginger–turmeric combination is also considered synergistic. [91]
Strongly recommended to include piperine in all curcumin formulations to inhibit glucuroconjugation and maximise bioavailability. [90] Piperine is synergistic with curcumin in preventing senescence. [89] Ayurvedic medicine combined black pepper, long pepper and ginger for similar effect. [92]
Soy lecithin–curcumin association improves absorption of curcuminoids. [93] Multiple studies confirm significantly improved oral bioavailability versus plain curcumin.
Curcuminoid-rich extracts encapsulated with gamma-cyclodextrin for improved relative oral bioavailability in human subjects. [94]
Turmeric rhizome officially listed in the Pharmacopée Française, List A — the highest pharmacopoeial recognition in France. Monograph developed in collaboration with China's State Food and Drug Administration.
The French national food safety agency ANSES issued an opinion evaluating the risks related to consumption of dietary supplements containing turmeric (May 2022). Hepatotoxicity cases have been reported with high-dose curcumin supplements. [1]
Contraindicated combinations: Camptothecin (Campto®), doxorubicin (Adriamycin®), mechlorethamine & cyclophosphamide (Endoxan®), vincristine (Oncovin®) — risk of partial inhibition of efficacy. Possible combinations (experimental synergy): Gemcitabine (Gemzar®), paclitaxel (Taxol®), docetaxel (Taxotere®), oxaliplatin (Eloxatin®). [103]
Review of documented adverse effects, contraindications, and patient-specific precautions.